Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Inhalon Biopharma Logo
Inhalon Biopharma Growth Score
25
CB Rank
61739
Heat Score
50
Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.
Founded
obfuscation
PrivateGrant Carrboro, North Carolina, United States1-10 www.inhalon.com/
Biopharma
Biotechnology
Overview

Inhalon Biopharma
Total Funding
obfuscation
Growth Score
25
Heat Score
50

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score25
-2 pts
in past quarter
Heat Score 50
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Inhalon Biopharma

CB Rank
61739
Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.
Founded
obfuscation
PrivateGrant Carrboro, North Carolina, United States1-10 www.inhalon.com/
Biopharma
Biotechnology

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Inhalon Biopharma, Inc.
Operating Status Active
Company Type For Profit
Founders  Samuel Lai, Thomas Moench
About the Company
Inhalon Biopharma is into developing monoclonal antibodies (mAb) using technology that enables trapping of pathogens in mucus secretions for treating diseases of the respiratory tract.
Phone Number 607-279-1880
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

IN-006
An inhaled monoclonal antibody treatment targeting SARS-CoV-2, designed for direct delivery to the respiratory tract via nebulization.
IN-002
An inhaled monoclonal antibody treatment candidate for respiratory syncytial virus (RSV), delivered via nebulization to the lungs.

Research & Development

Inhalon Biopharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant
obfuscation
Grant - Inhalon Biopharma Logo
Grant - Inhalon Biopharma
1
obfuscation
CollaboratoryGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Board Members and Advisors 1 Contacts 7

Employee Profiles

Board Members and Advisors

News

News and Press

News•Feb 14, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

19
-92.91%
 in past month

IT Spend

$119.8KThis year, Inhalon Biopharma is projected to spend $119.8K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Harassment Logo
Harassment
73
Generational Difference Logo
Generational Difference
69

Active Website Tech Count

2Inhalon Biopharma is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m.

Total IP

1Inhalon Biopharma has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Inhalon Biopharma's headquarters? Inhalon Biopharma is located in Carrboro, North Carolina, United States.Who invested in Inhalon Biopharma? Inhalon Biopharma has 5 investors including Collaboratory and  U.S. Army Medical Research & Development Command.When was the last funding round for Inhalon Biopharma? Inhalon Biopharma closed its last funding round on
obfuscation
from a Grant round.Who are Inhalon Biopharma's competitors? Alternatives and possible competitors to Inhalon Biopharma may include AstraZeneca, Climb Bio, and  Vir Biotechnology.How much funding has Inhalon Biopharma raised to date? Inhalon Biopharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|